Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease.
about
Autosomal dominant polycystic kidney disease: the last 3 yearsPolycystic liver diseases: advanced insights into the molecular mechanismsHDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesisPolycystic liver disease: an overview of pathogenesis, clinical manifestations and management.Isolated polycystic liver disease.Role of follicle-stimulating hormone on biliary cyst growth in autosomal dominant polycystic kidney disease.Novel targets for the treatment of autosomal dominant polycystic kidney disease.Polycystic liver diseases.Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice.Recent advances on the mechanisms regulating cholangiocyte proliferation and the significance of the neuroendocrine regulation of cholangiocyte pathophysiology.ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice.Food Restriction Ameliorates the Development of Polycystic Kidney Disease.Role of sex hormones in the modulation of cholangiocyte function.Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseasesPasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases.Taurocholate feeding to bile duct ligated rats prevents caffeic acid-induced bile duct damage by changes in cholangiocyte VEGF expression.Cholangiociliopathies: genetics, molecular mechanisms and potential therapiesCrosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging.Expression of vascular endothelial growth factors and their receptors by hepatic progenitor cells in human liver diseases.Systematic review: the pathophysiology and management of polycystic liver disease.Diagnosis and management of polycystic liver disease.Therapeutic Targets in Polycystic Liver Disease.Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease.An update on the pathophysiology and management of polycystic liver disease.The cholangiocyte primary cilium in health and disease.Pleuritic chest pain from portal hypertensive gastropathy in ESRD patient with autosomal dominant polycystic kidney disease misdiagnosed as pericarditis.Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib.Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling.Close pathological correlations between chronic kidney disease and reproductive organ-associated abnormalities in female cotton rats.Disrupted cell adhesion but not proliferation mediates cyst formation in polycystic liver disease.
P2860
Q24656249-7E3D860F-78C5-4E5B-8F5C-25D8BD9B7E57Q27001174-A12A5E76-C4E0-41AD-9782-A2DC8D342896Q28572123-2A6A78B6-73A6-4ECD-821A-CC48EF1AEFB5Q33648233-67EC1F83-73AF-4AC3-A433-CA04818E25DCQ33723830-F42C14CB-F5C7-4BB6-9D07-955D83454B9EQ33783730-FFF4FEFD-C96A-41EB-8A6E-0326B62B3806Q33816594-2EDC1EBD-FF10-4DB0-AEAC-5DFC2BF5DDF1Q33949172-BCBC9389-F9FB-47E3-AB89-BB343056050DQ34091331-FAB44DF9-F973-4701-B70A-2F6BC468F2C7Q34358007-0D158BA9-E044-41C6-873F-DDB2A1756426Q34399971-1C883840-B60E-444B-AFA8-F38B13F52B40Q34500619-A8A123C9-F4B1-446A-BCA7-125405E693D9Q34992322-09EDC3D6-F5BD-427B-90E1-1162D57EA57CQ35185224-E904DD39-CE78-4D12-ADEC-A40405580EB9Q36739229-2B5AF049-9DD0-4E15-B0E6-E3418519311AQ37157705-F2270CC7-619E-43DE-B8C3-A61369BE0838Q37317821-5AF7F9A0-C09E-4139-BCAB-57B9B8A4A6A1Q37327417-B1768D72-8BEB-4554-B6AB-87DA9C8E2DCDQ37584658-3368B73E-AA67-463C-8AE2-516501F10EA2Q37905881-3B026935-EEFE-4F73-99EB-2BC986BEDD0DQ38072284-FBBE9EE3-EA8F-4777-841A-8FB9E9E447ABQ38443908-CA7A43A9-840E-4D10-AEC7-5C8337285019Q38737946-58993348-A709-431E-BA18-C91E1904D495Q39186912-52FCF4EE-A8E2-470E-BBC9-B14C6492888CQ39381392-41257C20-26A7-4079-92A8-ECB129482016Q40025433-9AECB411-CF91-43F7-BCAB-4639B179AE7CQ42213282-212BAE47-9E13-4DEA-A5BC-EB4B298041ADQ47706205-DD98CB08-2306-4C41-96ED-22C2FD3F816DQ48090042-36BAEF35-1F18-4D2C-A498-5B6DA25566DCQ52587753-C85D1B6D-73E7-47A1-9BBA-A80733C7B795
P2860
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Morphological and functional f ...... ant polycystic kidney disease.
@ast
Morphological and functional f ...... ant polycystic kidney disease.
@en
type
label
Morphological and functional f ...... ant polycystic kidney disease.
@ast
Morphological and functional f ...... ant polycystic kidney disease.
@en
prefLabel
Morphological and functional f ...... ant polycystic kidney disease.
@ast
Morphological and functional f ...... ant polycystic kidney disease.
@en
P2093
P2860
P50
P1476
Morphological and functional f ...... ant polycystic kidney disease.
@en
P2093
Alessia Torrice
Douglas M Jefferson
Eugenio Gaudio
Fabrizio Stefanelli
Gianfranco Alpini
Maria Grazia Mancino
Mario Strazzabosco
P2860
P304
P356
10.2353/AJPATH.2008.070293
P407
P50
P577
2008-01-17T00:00:00Z